Quick Answer
LifeStance Health Group, Inc. reported Cash and Equivalents of $248.64 million for fiscal year 2025.
LifeStance Health Group, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $248.64M | +60.9% |
| 2024 | $154.57M | +96.1% |
| 2023 | $78.82M | -27.4% |
| 2022 | $108.62M | -26.6% |
| 2021 | $148.03M | +686.2% |
| 2020 | $18.83M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $203.90M | +98.7% | +7.9% |
| June 30, 2025 | $188.93M | +117.2% | +40.6% |
| March 31, 2025 | $134.34M | +171.7% | -13.1% |
| December 31, 2024 | $154.57M | +96.1% | +50.6% |
| September 30, 2024 | $102.61M | +140.9% | +18.0% |
| June 30, 2024 | $86.97M | +9.3% | +75.9% |
| March 31, 2024 | $49.45M | -27.6% | -37.3% |
| December 31, 2023 | $78.82M | -27.4% | +85.0% |
- LifeStance Health Group, Inc. showed an increase of +60.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, LifeStance Health Group, Inc.’s cash and equivalents has grown by 1220.5% (from $18.83 million to $248.64 million).
- The most recent figure is from LifeStance Health Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: